8,995 Synopsys, Inc. $SNPS Shares Sold by Candriam S.C.A.

Key Points

• Candriam S.C.A. reduced its Synopsys stake by 18.8% in the third quarter, selling 8,995 shares and retaining 38,905 shares worth about $17 million.
• Institutional investors collectively own 85.47% of Synopsys, with several firms adding shares even as Candriam cut its position. The company also authorized a $1 billion stock buyback.
• Synopsys beat quarterly earnings and revenue estimates, with revenue up 42.4% year over year. Analysts’ consensus rating is “Moderate Buy,” with an average price target of $575.

Candriam S.C.A. cut its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 18.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 38,905 shares of the semiconductor company's stock after selling 8,995 shares during the quarter. Candriam S.C.A.'s holdings in Synopsys were worth $16,983,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of SNPS. Kornitzer Capital Management Inc. KS boosted its position in shares of Synopsys by 96.7% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 3,979 shares of the semiconductor company's stock worth $1,731,000 after buying an additional 1,956 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in Synopsys by 90.8% during the 3rd quarter. Pictet Asset Management Holding SA now owns 1,132,130 shares of the semiconductor company's stock valued at $492,223,000 after acquiring an additional 538,737 shares in the last quarter. Formidable Asset Management LLC increased its holdings in Synopsys by 133.3% during the 3rd quarter. Formidable Asset Management LLC now owns 4,153 shares of the semiconductor company's stock valued at $1,833,000 after acquiring an additional 2,373 shares in the last quarter. Tamar Securities LLC raised its position in Synopsys by 0.9% during the third quarter. Tamar Securities LLC now owns 54,453 shares of the semiconductor company's stock worth $23,684,000 after acquiring an additional 488 shares during the last quarter. Finally, United Advisor Group LLC raised its position in Synopsys by 57.6% during the third quarter. United Advisor Group LLC now owns 1,291 shares of the semiconductor company's stock worth $562,000 after acquiring an additional 472 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Performance

NASDAQ:SNPS opened at $450.46 on Monday. The firm has a 50 day simple moving average of $441.61 and a 200-day simple moving average of $442.27. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The firm has a market cap of $86.33 billion, a PE ratio of 79.59, a P/E/G ratio of 1.43 and a beta of 1.18. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analysts' expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys's revenue for the quarter was up 42.4% on a year-over-year basis. During the same period in the previous year, the company earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts expect that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its Board of Directors has authorized a stock buyback program on Monday, October 5th that authorizes the company to buy back $1 billion in shares. This buyback authorization authorizes the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares in the company, valued at approximately $35,576,196.60. This represents a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the firm's stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the completion of the sale, the insider directly owned 16,534 shares in the company, valued at approximately $8,308,665.68. The trade was a 6.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 117,163 shares of company stock worth $51,366,457 in the last three months. Company insiders own 0.56% of the company's stock.

Wall Street Analyst Weigh In

SNPS has been the topic of several recent research reports. Zacks Research raised shares of Synopsys from a "hold" rating to a "strong-buy" rating in a report on Friday, October 2nd. Wells Fargo & Company lifted their price objective on Synopsys from $475.00 to $540.00 and gave the stock an "overweight" rating in a research report on Thursday, October 1st. Rothschild & Co Redburn cut their price objective on Synopsys from $560.00 to $550.00 and set a "buy" rating for the company in a research report on Wednesday, September 23rd. Bank of America upped their target price on Synopsys from $500.00 to $600.00 in a research note on Thursday, October 1st. Finally, UBS Group set a $570.00 target price on Synopsys in a report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Synopsys has a consensus rating of "Moderate Buy" and an average price target of $575.00.

Synopsys Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.